共 9 条
- [1] Monclair T., Brodeur G.M., Ambros P.F., Et al., The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report, J Clin Oncol, 27, pp. 298-303, (2009)
- [2] Brisse H.J., McCarville M.B., Granata C., Et al., Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project, Radiology, 261, pp. 243-257, (2011)
- [3] Parhar D., Joharifard S., Lo A.C., Schlosser M.P., Daodu O.O., How well do image-defined risk factors (IDRFs) predict surgical outcomes and survival in patients with neuroblastoma? A systematic review and meta-analysis, Pediatr Surg Int, 36, pp. 897-907, (2020)
- [4] Strother D.R., London W.B., Schmidt M.L., Et al., Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children’s Oncology Group study P9641, J Clin Oncol, 30, pp. 1842-1848, (2012)
- [5] Baker D.L., Schmidt M.L., Cohn S.L., Et al., Outcome after reduced chemotherapy for intermediate-risk neuroblastoma, N Engl J Med, 363, pp. 1313-1323, (2010)
- [6] Iehara T., Yoneda A., Yokota I., Et al., Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: a report from the Japan Children’s Cancer Group Neuroblastoma Committee, Pediatr Blood Cancer, 66, (2019)
- [7] Meany H.J., Non-high-risk neuroblastoma: classification and achievements in therapy, Children (Basel), 6, (2019)
- [8] Nuchtern J.G., London W.B., Barnewolt C.E., Et al., A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children’s Oncology Group study, Ann Surg, 256, pp. 573-580, (2012)
- [9] Yoneda A., Nishikawa M., Uehara S., Et al., Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis?, Pediatr Surg Int, 32, pp. 209-214, (2016)